{"schema_version":"secwatch.filing_event.v1","accession":"0001681622-24-000008","form_type":"8-K","ticker":"VREX","cik":"0001681622","company_name":"Varex Imaging Corp","filed_at":"2024-02-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.097734+00:00","generated_at":"2026-06-06T08:15:58.043245+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Varex Q1 FY2024 revenue $190M (-8% YoY), GAAP loss $0.01/sh, non-GAAP EPS $0.06","bullets":["Revenue $190M, down 8% YoY; Medical segment $140M (-13%), Industrial $50M (+10%).","GAAP net loss $0.01/diluted share; Non-GAAP EPS $0.06 vs $0.21 in prior year.","Non-GAAP gross margin 31% (vs 32% YoY); operating margins declined.","Cash from operations $10M; cash & equivalents $195M, flat vs FY2023 year-end.","Q2 FY2024 guidance: revenue $195-215M, non-GAAP EPS $0.10-$0.30."],"urls":{"canonical":"https://secwatch.observer/filing/0001681622-24-000008","json":"https://secwatch.observer/filing/0001681622-24-000008.json","markdown":"https://secwatch.observer/filing/0001681622-24-000008.md","text":"https://secwatch.observer/filing/0001681622-24-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1681622/000168162224000008/0001681622-24-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1681622/000168162224000008/vrex-20240206.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T08:15:58.043245+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3f5471404128d0936e6644560665a05cfd0d5293","claim":"Varex Imaging Corp reported three months ended December 29, 2023 results: revenue $190 million.","evidence_excerpt":"February 6, 2024 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter of fiscal year 2024. 1QFY24 Summary • Revenues $190 million • GAAP gross margin 30% | Non-GAAP gross margin* 31% • GAAP operating margin 2% | Non-GAAP operating margin* 5% • GAAP net loss $0.01 per diluted share | Non-GAAP net earnings*","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1681622/000168162224000008/0001681622-24-000008-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended December 29, 2023"},{"label":"Revenue","value":"$190 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"8c4f47e79115fa3a9ef05ababcb46ac2ee8daa8c","claim":"Varex Imaging Corp reported first quarter of fiscal year 2024 results: revenue $190 million.","evidence_excerpt":"Revenue of $190 million in the first quarter of fiscal 2024, was at the mid-point of our guidance, however unfavorable mix in both the Medical and Industrial segments impacted profitability.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1681622/000168162224000008/0001681622-24-000008-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter of fiscal year 2024"},{"label":"Revenue","value":"$190 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}